2nd quarter revenue per employee for 12 big pharma companies
The chart below presents the 2011 2nd quarter revenue per employee for the 12 largest bio pharmaceutical firms.
The unweighted average was $146,235.86. The median was $135,712. Amgen has the largest ratio of $227,660
in 2nd quarter revenue per employee.
| Firm | 2011 2nd quarter revenue (millions of USD) | Employment | Quarterly revenue per employee |
| J&J | $16,597 | 115,000 | $144,322 |
| Roche | $10,836 | 80,653 | $134,347 |
| Novartis | $14,915 | 119,418 | $124,897 |
| Pfizer | $16,984 | 110,600 | $153,562 |
| Merck | $12,151 | 91,000 | $133,527 |
| Sanofi | $8,349 | 101,575 | $82,195 |
| Abbott | $9,616 | 90,000 | $106,844 |
| AstraZeneca | $8,292 | 61,100 | $135,712 |
| Amgen | $3,893 | 17,100 | $227,661 |
| BMS | $5,434 | 27,000 | $201,259 |
| Lilly | $6,253 | 38,065 | $164,266 |
One firm left off this list is Gilead, a firm with 4,000 employees and $2.137 billion in 2011 2nd Quarter revenues — a ratio of $534,313 per employee for the quarter, more than twice the amount for Amgen.